Cyclic lipopeptide (CLP) antibiotics have a mechanism that causes membrane malfunction. Thus mechanisms of bacterial resistance to CLPs are thought to modify cell surfaces. However, we found that bacterial resistance to CLPs was strongly related to energy metabolism. Using polymyxin B (PB) as a model of CLPs, we showed that PB causes malfunction of respiration and serious depletion of ATP, contributing to PB-induced cell death and carbon starvation. Glucose addition could maintain the intracellular ATP level and reverse the carbon starvation response resulting from PB treatment. Another study revealed that glycolysis was stimulated by the presence of PB and glucose. The mechanism underlying glucose-enabled CLPs' resistance suggests that glucose could maintain the ATP level in PB-treated bacteria by enhancing glycolysis. Similar results were observed in Staphylococcus aureus, where daptomycin resistance was enhanced by glucose. These findings provide insight into the mode of action of CLPs and resistance to these antibiotics.
INTRODUCTION
Antibiotics are useful for treating bacterial infections. However, the worldwide emergence of drug-resistant bacteria is a great threat to antibiotic efficacy. Cyclic lipopeptides (CLPs) produced by diverse groups of bacteria are receiving more and more attention because of their broad-spectrum activity against microorganisms, including multidrug-resistant pathogens (Baltz, 2009; Straus and Hancock, 2006) . All CLPs are composed of a circular oligopeptide linked to a fatty acid chain. They also have a similar mode of action, which involves membrane integrity impairment and dissipation of membrane potential (Straus and Hancock, 2006) . In recent years, studies have revealed that CLPs might have a second mode of action (Baltz, 2009; Hamamoto et al., 2015; Trimble et al., 2016; Xing et al., 2014) . A recently identified CLP, lysocin E, was shown to inhibit respiration in Staphylococcus aureus by directly interacting with menaquinone (Hamamoto et al., 2015) . The well-studied daptomycin (DAP) could cause dissipation of membrane potential and cell death without damaging membrane integrity. Moreover, polymyxin B (PB) was found to inhibit NADH dehydrogenase (NDH) from the gram-positive bacterium M. smegmatis (Mogi et al., 2009) . DAP and PB are two important CLPs that have been used in medical treatment for decades. Unfortunately, pathogens resistant to DAP and PB have emerged (Miller et al., 2016) . However, knowledge of the CLPs' resistance mechanism is restricted to the modification of the cell wall, cell membrane, or outer membrane (Bayer et al., 2013; Fischer et al., 2011; Wosten et al., 2000) . The dlt operon in S. aureus could reduce the negative charge of the cell surface and keep DAP away from the cell membrane (Bayer et al., 2013) . MprF is a DAP-resistant protein responsible for lysinylation of PG, which also reduces the negative charge of the cell surface in S. aureus (Bayer et al., 2013) . Fischer et al. compared the transcriptomic and proteomic profiles of a DAP-resistant methicillin-resistant S. aureus strain with those of the DAP-sensitive strain (Fischer et al., 2011) . Their results showed that many genes involved in cell wall metabolism were significantly up-regulated in the DAP-resistant isolate, indicating the important role of cell wall in DAP resistance (Fischer et al., 2011) . PmrA-PmrB in Salmonella is a two-component system that responds to the cellular iron level, induces the expression of genes involved in outer membrane modification, and confers PB resistance (Wosten et al., 2000) .
Glucose is a prior carbon source that can support rapid growth of microorganisms (Sonenshein, 2007) . Several recent studies showed that glucose and other carbon sources such as mannitol, fructose, and glycerol could affect the antibiotic sensitivity of the microorganism by regulating the metabolic state. Allison et al. found that these carbon sources could activate the membrane potential of Escherichia coli persisters, (Allison et al., 2011) . Similarly, Peng et al. showed that glucose could restore antibiotic-resistant bacterial sensitivity to antibiotics by increasing the proton motive force (PMF), which mediates the uptake of antibiotics (Peng et al., 2015) . Here, we found that glucose and some carbon sources exert an effect on bacterial resistance to CLPs and reveal a distinct mechanism underlying interaction between the metabolic state of bacteria and the bactericidal activity of antibiotics. PB caused respiratory malfunction and serious depletion of ATP, contributing to PB-induced cell death and an obvious carbon starvation response. The addition of glucose could maintain the intracellular ATP level and reverse the carbon starvation response resulting from treatment of PB. The results indicated that glucose induced bacterial resistance to PB by maintaining the intracellular ATP level in PB-treated bacteria through enhanced glycolysis. Similar results were also observed in S. aureus, where DAP resistance was enhanced by glucose. These findings demonstrated that the intracellular ATP level was important for the mode of action of CLPs, and they provide insight into bacterial resistance to these antibiotics.
RESULTS

Glucose-Induced Drug Resistance to CLPs
We previously studied the mode of action of CLPs on B. subtilis using transcriptome analysis, which revealed that CLPs caused significant carbon starvation (Yu et al., 2012) . We wondered if the bactericidal activity of CLPs was related to carbon metabolism. Here, we investigated the effect of some carbon sources (20 mM glucose, fructose, glycerol, and arabinose) on the bactericidal activity of PB in B. subtilis ( Figures 1A  and B ). B. subtilis cells incubated in Luria broth medium with or without carbon sources were treated with 50 mg/mL PB. As shown in Figures 1A and 1B , both glucose and fructose significantly enhanced drug resistance to PB in B. subtilis. Glycerol and arabinose had weaker effect on PB resistance in B. subtilis ( Figure 1B ). To study if glucose-induced resistance is applicable to other CLPs, we tested the effect of glucose on B. subtilis' resistance to DAP. As shown in Figure 1C , glucose also enhanced B. subtilis' resistance to DAP. With increase in glucose concentrations, bacterial resistance to DAP increased. However, these results showed that higher concentration of glucose (15 mM) was needed to completely inhibit the activity of DAP with a concentration of 5 mg/mL ( Figure 1C ). This might be because the activity of DAP is more efficient than that of PB when treating B. subtilis. We also tested if glucose induced resistance to other cationic antimicrobial peptides (such as vancomycin [VAN] ). However, with the presence of glucose, resistance of B. subtilis to VAN was not enhanced ( Figure 1D ).
To investigate the relationship between carbon metabolism and the action of CLPs, proteomic analysis was performed with B. subtilis cells treated with PB, PB plus glucose, or glucose. After applying a cutoff value of 1.2-fold change (p < 0.05), the expressions of 805, 594, and 478 proteins were found to be significantly changed after treatment by PB, PB plus glucose, or glucose, respectively ( Figure S1 and Table S1 ). As shown in the Figure 2, MalP and ManP were involved in mannose uptake, MtlA was involved in mannitol uptake, LevDE was involved in fructose uptake, GlpTK was involved in glycerol uptake, AcoL was involved in acetoin catabolism, RocG was involved in glutamate catabolism and the proteins SdhAB that compose the succinate dehydrogenase complex, AcsA was involved in acetate utilization, and GapB was involved in glucogenesis, and they were all significantly up-regulated in PB-treated B. subtilis ( Figure 2 ). However, no change was observed in B. subtilis treated with PB plus glucose ( Figure 2 ). Pgi, Pgk, Eno, FbaA, and Ldh were involved in the glycolysis pathway, and they were significantly down-regulated by PB treatment. None of them were down-regulated after treatment with PB plus glucose. In B. subtilis, alternative carbon acquisition or metabolism is repressed, whereas catabolism of glucose is activated by CcpA, which senses the energy status of the cell and is activated by fructose-1,6-bisphosphate (FBP) or high ATP concentrations (Ludwig et al., 2001; Sonenshein, 2007) . These results might indicate that PB resulted in a lower energy status before being reverted by glucose.
The proteins involved in respiration are also shown in Figure 2 . PB repressed cytochrome caa3 (CtaCDF), menaquinol-cytochrome c reductase (QcrABC), and cytochrome bd (CydA) expression, but it induced NADH-Q dehydrogenase (YjlD, renamed Ndh) and succinate dehydrogenase (SdhAB) expression. It seems that PB led to respiratory malfunction. Mogi et al. reported that PB can inhibit NADH-Q dehydrogenase in M. smegmatis (Mogi et al., 2009) . It is possible that PB could inhibit NADH-Q dehydrogenase, causing NADH/NAD + and Q/QH 2 increases that lead to Ndh induction and repression of CtaCDF, QcrABC, and CydA. In B. subtilis, Ndh expression is induced by an increased NADH/NAD + ratio (Gyan et al., 2006) , whereas CydA, QcrABC, and CtaCDF expression might be repressed due to an increased Q/QH 2 ratio (Geng et al., 2007) . After PB plus glucose treatment, expression of QcrABC and CtaCDF was also significantly repressed. However, Ndh expression was less up-regulated, and CydA was significantly upregulated. These observations indicated that glucose could revert the NADH/NAD + increase and cause some degree of respiratory malfunction.
PB Inhibited NADH Dehydrogenase and ATP Synthesis, Leading to ATP Depletion
The proteomics results revealed an increase in the NADH/NAD + ratio, and Mogi et al. reported that PB can inhibit NADH-Q dehydrogenase in M. smegmatis. We reasoned that PB might also inhibit respiratory NDH in B. subtilis (Mogi et al., 2009) . To test this, B. subtilis cell membrane preparation was treated with or without PB in the presence of menaquinone and NADH. As shown in Figure 3 , the decreasing velocity of NADH was much slower with PB, indicating that NDH enzyme activity was inhibited by PB ( Figure 3A) . The IC50 values of PB to NDH were determined to be 18.82 mg/mL. B. subtilis is a facultative anaerobe whose ATP was mainly supplied by aerobic respiration under aerobic conditions. Inhibition of respiratory NDH might inhibit ATP synthesis. Moreover, PB causes dissipation of PMF, which activates F0-F1 ATP synthetase (Maloney et al., 1974) . This result suggested that PB might inhibit ATP synthesis in vivo. The intracellular ATP level in PB-treated bacteria was determined using the ATP-analyzing kit. We found that the ATP level decreased in PB-treated bacteria in a dose-dependent manner ( Figure 3B ). To examine if ATP depletion results in the bactericidal action of PB, B. subtilis was pretreated with 1 mM dicyclohexylcarbodiimide (DCCD), which is an inhibitor of F0-F1 ATP synthase. As shown in Figures 3C and 3D , B. subtilis pretreated with DCCD were more sensitive to PB, which is indicated by a faster OD600 drop and lower ATP level. These results indicated that PB caused ATP depletion and contributed to cell death.
Glucose Maintained the Intracellular ATP Level in PB-Treated B. subtilis
Glucose is a key carbon source that supplies energy for bacterial growth (Sonenshein, 2007) . This could keep the intracellular ATP level in PB-treated bacteria. To test this, the intracellular ATP levels were analyzed in the presence of PB, PB plus glucose, or glucose. As shown in Figure 4 , ATP levels in PB-treated bacteria were much lower than that in the control. However, this was reverted by glucose, which increased the ATP level in the PB-treated bacteria to about 2-fold compared with control ( Figure 4) . It was noted that the ATP level in the PB plus glucose treatment was much lower than in the glucose only treatment, indicating that PB still inhibited ATP synthesis even in the presence of glucose.
In bacteria, glucose can generate ATP via glycolysis or the electron transport chain (ETC). To investigate if glucose enhanced ATP synthesis via ETC after PB treatment, we examined the PMF of the B. subtilis treated with PB or PB plus glucose. As shown in Figure 5A , the PMF of PB-treated bacteria was increased to some degree by glucose, but that was still lower than the PMF of the untreated bacteria. Fructose that enabled drug resistance had no effect on the PMF in PB-treated bacteria ( Figure 5A ). As glucose did not restore the PMF to the control level, we suggested that glucose might stimulate glycolysis to generate ATP in the presence of PB. To support this, we determined the intracellular metabolites (glucose, pyruvate, and acetate) of the glycolytic pathway to analyze glycolytic activity. As shown in Figures 5B-5D , the intracellular levels of these metabolites were significantly lower in the PB-treated B. subtilis than in the untreated ones, indicating that PB led to carbon source depletion and low glycolytic activity. However, the intracellular concentrations of glucose, pyruvate, and acetate were greatly increased in the PB treatment plus glucose, suggesting that glucose reverses carbon starvation and low glycolysis in the PB-treated bacteria. In the presence of PB, B. subtilis would uptake more glucose and increase the glycolytic pathway flux. These results showed that glucose induced bacterial resistance to PB by increasing intracellular ATP level via enhancement of glycolysis. 
Glycolysis Is the Key Pathway that Enables PB Resistance in B. subtilis
To confirm that glycolysis enables PB resistance, the bacteria were treated with cysteine, an inhibitor of pyruvate kinase, to inhibit glycolysis flux (Kedryna et al., 1983) . As shown in Figure 6A , in the presence of cysteine, glucose could not induce resistance to PB in B. subtilis. We also tested the effect of the tricarboxylic acid (TCA) cycle on glucose-enabled drug resistance by treating B. subtilis with a high concentration of malonic acid (20 mM), an inhibitor of succinate dehydrogenase, to inhibit TCA flux (Lu et al., 2018) ( Figure 6C ). Malonic acid did not eliminate glucose-enabled drug resistance, but the live percentage of the PB plus glucose plus malonic acid treatment was slower than the PB plus glucose treatment. These observations demonstrated that glycolysis was essential in glucose-enabled drug resistance, but the TCA cycle was not essential. Glucose catabolism could generate NADH, which is oxidized by ETC, contributes to PMF, and activates F0-F1 ATP synthase to generate ATP. Next, we investigated the effect of F0-F1 ATP synthase on glucose-enabled resistance by treating B. subtilis with DCCD, an inhibitor of F0-F1 ATP synthase (Rao et al., 2008) . With a DCCD supplement, we found that PB resistance could be eliminated by 2 mM DCCD. This result indicated that F0-F1 ATP synthase might also contribute to glucose-enabled drug resistance ( Figure 6B ). 
Glucose Also Induced Bacterial Resistance to CLPs in Staphylococcus aureus
After showing that glucose induces resistance to CLPs in B. subtilis, we investigated if the phenomenon is applicable to S. aureus. As S. aureus is not sensitive to PB, we treated S. aureus with DAP (5 mg/mL). The results showed that DAP also resulted in serious ATP depletion leading to cell death in S. aureus ( Figures  7A and 7B) . With the addition of glucose, the ATP level was maintained and the killing activity of DAP was inhibited ( Figures 7A and 7B) . Moreover, we observed that glucose-induced drug resistance to CLPs in S. aureus was eliminated by cysteine ( Figure 7A) . Collectively, these observations demonstrated that glucose induces bacterial resistance to CLPs in S. aureus through the same mechanism as it does in B. subtilis.
DISCUSSION
Previous knowledge about the mechanism of CLPs' resistance in bacteria was restricted to cell surface modifications. However, we found that glucose could enable bacterial resistance to CLPs. To understand how glucose enables bacterial resistance to CLPs, we re-investigated CLPs' action using PB as a model CLP. The CLPs' mechanism was supposed to destroy lipid bilayer membrane integrity and cause dissipation of membrane potential (Straus and Hancock, 2006) . However, several studies showed that the destruction of membrane integrity was not the sole killing mechanism in the action of CLPs (Baltz, 2009; Hamamoto et al., 2015; Mogi et al., 2009; Trimble et al., 2016; Xing et al., 2014) . That is because cellular processes such as cell division, cell wall component synthesis, and energetics are affected by membrane integrity (Baltz, 2009; Straus and Hancock, 2006) . In a recent study by Mogi et al., PB was found to be a potent inhibitor of membrane-bound NDH from M. smegmatis, indicating that PB might disturb the energetic status (Mogi et al., 2009) . Here, we investigated the energy status of PB-treated bacteria. We found that PB would cause significant ATP depletion in B. subtilis. This contributed to its killing action, indicating that energetics is a PB target. Furthermore, we found that glucose could maintain the intracellular ATP level in PB-treated bacteria. We suggested that glucose enables bacterial PB resistance by maintaining the ATP level.
To scrutinize how glucose maintains the ATP level in PB-treated bacteria, we used proteomic analysis to investigate the metabolic status of bacteria after PB treatment. The results revealed that PB inhibited membrane-bound NDH in B. subtilis and caused down-regulation of respiration complexes, indicating that PB caused respiratory malfunction. PB treatment also caused PMF dissipation. These were the reasons why PB caused ATP depletion. PB treatment caused a significant response of carbon starvation. First, many proteins involved in transport and catabolism of alternative carbon sources were up-regulated (Ludwig et al., 2001; Sonenshein, 2007) . Second, PB treatment also caused significant decrease in the levels of carbon metabolites in vivo, including glucose, pyruvate, and acetate. Thus, this could be explained by the fact that PB leads to low energy status and so more carbon sources were catabolized to maintain the energy status for survival. As a result, in vivo carbon metabolites were exhausted. However, this carbon starvation state was reverted by glucose. With a supplement of glucose, the bacteria could achieve enough carbon sources for survival. Owing to inhibition of respiration, the bacteria might maintain the energy status by enhancing glycolysis. To confirm this hypothesis, we compared the levels of the glycolytic metabolites, including glucose, pyruvate, and acetate in PB/glucose-and glucose-treated bacteria. The results showed that levels of the glucose, pyruvate, and acetate are much higher in PB/glucose-treated bacteria, demonstrating that glycolysis was enhanced by PB.
We also explored the role of the TCA cycle and F0-F1 ATP synthase in glucose-enabled drug resistance. The drug resistance could be eliminated by a high concentration of DCCD but not by malonic acid. This indicated that F0-F1 ATP synthase might partially contribute to PB resistance, but TCA does not. It seemed that glycolysis alone could not sustain survival of PB-treated bacteria in the glucose test concentration range. However, DCCD might have an additional effect, which causes dissipation of PMF in B. subtilis (Calamita et al., 2001) . As glucose had no significant effect on restoration of the PMF, DCCD may cause a further dissipation of PMF, which may lead to cell lysis in B. subtilis (Calamita et al., 2001 ).
Inhibition of NDH will restrict NADH/NAD + turnover leading to NAD + limitation in vivo (Gyan et al., 2006) . As NAD + is the main oxidant in the cell, restoration of the NAD + pool makes NADH turnover a top priority compared with ATP synthesis . As seen in the proteomic results, NDH expression was 2fold up-regulated in PB treatment but 1.3-fold up-regulated in PB plus glucose treatment. This indicated that glucose might revert the increase in NADH/NAD + . Here, we noted that NadA and NadB involved in NAD + synthesis were significantly up-regulated (2.2-fold and 3.2-fold, respectively) with glucose supplement, but these two proteins were down-regulated (0.51-fold and 0.60-fold, respectively) with PB treatment. Thus, it was possible that glucose increased the NAD + pool to revert the increase in NADH/ NAD + . However, this hypothesis needs to be further confirmed.
This work demonstrated that bacterial sensitivity to CLPs is strongly related to energy metabolism. The relation between bacterial resistance to antibiotics and energy metabolism is also observed elsewhere Liu et al., 2019; Su et al., 2018) . Herein, we showed that CLPs could disturb ATP synthesis and cause cell death, but glucose can maintain the ATP level by enhancing glycolysis and enabling drug resistance (Figure 8 ). This study provides insight into the mode of action of CLPs and bacterial resistance mechanisms to CLPs.
Limitations of the Study
In this study, the molecular mechanism underlying ATP depletion induced by CLP antibiotics remains unclear.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file. 
Transparent Methods
Bacterial strains, materials, and growth conditions
Bacillus subtilis ATCC21616, Staphylococcus aureus ATCC12600 were firstly grown in glass flasks with the Luria-Bertani (LB) medium at 37 °C and 220 rpm. When the OD 600 of culture reach 0.3, the culture was split into 50 ml centrifuge tubes for adding polymyxin B (50 µg/ml), daptomycin (5 µg/ml), vancomycin (50 µg/ml), glucose (5-20 mM), fructose (20 mM), arabinose (20 mM), glycerol (20 mM), inhibitor et al. The final volume in each tube is 3ml. The same amount of bacteria culture was collected for ATP and metabolite detection. All carbon source, inhibitor and PB were purchased from Sigma Aldrich (St. Louis, MO, USA). Antibiotics were filtered with a 0.22 mm pore size hydrophilic PVDF membrane. Luria-Bertani (LB) were sterilized by autoclaving at 121 °C for 20 min. Bacillus subtilis ATCC21616 were grown to reach 1.0 of OD value for cell membrane preparation.
Screening of carbon source
Preparation of Bacillus subtilis membranes
After reaching an OD 600 of 1.0, Bacillus subtilis ATCC21616 cells were collected using centrifugation at 3,500 r.p.m. for 30 min at 4 °C and washed twice using buffer solution containing 30 mM Tris-HCl and 10 mM Na-EDTA (pH 7.5). Cells were resuspended with 30 mM Tris-HCl, 10 mM Na-EDTA (pH 7.5), and protease inhibitor cocktail. The strains were lysed using high pressure at 13-14 MPa and centrifuged at 12,000 g for 15 min at 4 °C. Membranes were recovered from the supernatant using centrifugation at 150,000 g for 60 min at 4 °C and resuspended with 30 mM Tris-HCl (pH 7.5).
Detection of NADH dehydrogenase activities
NADH dehydrogenase activity assays were started using 10 mg/ml membranes, 200 mM NADH, 100 mM Q1, 50 mM Tris-HCl (pH 7.5), and 0.05% Tween 20. In the realtime monitoring of the enzymatic reaction, measurements of absorbance at 340 nm were acquired every 30 s for 10 min. For inhibition studies, the reaction mixture was preincubated with polymyxin B (0, 20, 30, 40, 50, 75 , 100 µg/ml) for 10 min. The decreased values of absorbance were simulated using GraphPad Prism 5 (GraphPad Software, Inc., La Jolla, CA) to get the 50% inhibitory concentration (IC50) of polymyxin B.
ATP level determination
ATP detection kit was purchased from Beyotime Biotechnology (Shanghai, China). The kit is based on firefly luciferase which uses ATP to catalyze luciferin to produce fluorescence. When firefly luciferase and luciferin are both in excess, fluorescent production is proportional to the concentration of ATP. The same amounts of bacteria (10 8 cells) were lysed in ice water mixture for 15 min by ATP detection lysis buffer to release ATP. The fluorescence value was measured using the microplate reader SynergyTM Mx (Bio-Tek Instruments, Winooski, VT) after adding ATP detection reagent.
Determination of glucose and organic acid levels
The glucose detection kit was purchased from Sigma Aldrich (St. Louis, MO, USA). First, ATP phosphorylates glucose via hexokinase. In the presence of oxidation type nicotinamide adenine dinucleotide (NAD + ), glucose-6-phosphate was phosphorylated to produce 6-phosphoric acid-gluconic acid by glucose-6-phosphate dehydrogenase (G6PDH). In the oxidation reaction, the increased absorption value of 340 nm is directly proportional to the glucose concentration. The same amounts of bacteria (10 8 cells) were lysed in ice water mixture for 15 min by glucose detection lysis buffer to release glucose. The absorption value was measured using the microplate reader SynergyTM Mx (Bio-Tek Instruments, Winooski, VT) after adding the glucose assay reagent.
For determination of organic acids (pyruvate and acetate), 10 9 cells were collected. Metabolites from the cell pellets were extracted with 200 µl 5% HClO 4 in an ice bath for 15 min. After centrifugation at 10000 g for 5 min, the supernatant was neutralized with a K 2 CO 3 solution, and the KClO 4 precipitate was removed by centrifugation. Subsequently, the levels of organic acids were determined by High Performance Liquid Chromatography. HPLC condition was 0.013 M H 2 SO 4 at a flow rate of 1.0 mL/min and 40 °C. UV spectra were acquired at 210 nm.
